ARCHIVES

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

Memantine Can Delay Onset Of Cognitive Function Decline

November 30, 2012